Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects

NCT03071770 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Agios Pharmaceuticals, Inc.